Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf M Mesters

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
International Journal of Cancer|December 31, 2008
Combined anti-PDGFRalpha and PDGFRbeta targeting in non-small cell lung cancerNiels Reinmuth, Ruediger Liersch, Miriam Raedel, et al.
Molecular Pharmaceutics|August 28, 2015
Tumor Growth Inhibition via Occlusion of Tumor Vasculature Induced by N-Terminally PEGylated Retargeted Tissue Factor tTF-NGRCaroline Brand, Max Fröhlich, Janine Ring, et al.
Blood|January 9, 2003
Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myelomaGuido Bisping, Regine Leo, Doris Wenning, et al.
Annals of Neurology|December 11, 2012
Role of reduced ADAMTS13 in arterial ischemic stroke: a pediatric cohort studyMoritz Lambers, Neil A Goldenberg, Gili Kenet, et al.
Blood|January 31, 2009
Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experienceRalf Bieker, Torsten Kessler, Christian Schwöppe, et al.
Thrombosis Research|May 4, 2010
Tissue-factor fusion proteins induce occlusion of tumor vesselsChristian Schwöppe, Torsten Kessler, Thorsten Persigehl, et al.
International Journal of Oncology|August 3, 2007
Paracrine interactions of vascular endothelial growth factor and platelet-derived growth factor in endothelial and lung cancer cellsNiels Reinmuth, Sonja Rensinghoff, Miriam Raedel, et al.
International Journal of Oncology|November 3, 2010
Vascular infarction by subcutaneous application of tissue factor targeted to tumor vessels with NGR-peptides: activity and toxicity profileJohannes Dreischalück, Christian Schwöppe, Tilmann Spieker, et al.
Leukemia Research|May 3, 2015
Potentiating the activity of rituximab against mantle cell lymphoma in mice by targeting interleukin-2 to the neovasculatureNiklas Börschel, Christian Schwöppe, Caroline Zerbst, et al.
Radiology|June 15, 2007
Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in miceThorsten Persigehl, Ralf Bieker, Lars Matuszewski, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|December 31, 2008
Combined anti-PDGFRalpha and PDGFRbeta targeting in non-small cell lung cancerNiels Reinmuth, Ruediger Liersch, Miriam Raedel, et al.
Molecular Pharmaceutics|August 28, 2015
Tumor Growth Inhibition via Occlusion of Tumor Vasculature Induced by N-Terminally PEGylated Retargeted Tissue Factor tTF-NGRCaroline Brand, Max Fröhlich, Janine Ring, et al.
Blood|January 9, 2003
Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myelomaGuido Bisping, Regine Leo, Doris Wenning, et al.
Annals of Neurology|December 11, 2012
Role of reduced ADAMTS13 in arterial ischemic stroke: a pediatric cohort studyMoritz Lambers, Neil A Goldenberg, Gili Kenet, et al.
Blood|January 31, 2009
Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experienceRalf Bieker, Torsten Kessler, Christian Schwöppe, et al.
Thrombosis Research|May 4, 2010
Tissue-factor fusion proteins induce occlusion of tumor vesselsChristian Schwöppe, Torsten Kessler, Thorsten Persigehl, et al.
International Journal of Oncology|August 3, 2007
Paracrine interactions of vascular endothelial growth factor and platelet-derived growth factor in endothelial and lung cancer cellsNiels Reinmuth, Sonja Rensinghoff, Miriam Raedel, et al.
International Journal of Oncology|November 3, 2010
Vascular infarction by subcutaneous application of tissue factor targeted to tumor vessels with NGR-peptides: activity and toxicity profileJohannes Dreischalück, Christian Schwöppe, Tilmann Spieker, et al.
Leukemia Research|May 3, 2015
Potentiating the activity of rituximab against mantle cell lymphoma in mice by targeting interleukin-2 to the neovasculatureNiklas Börschel, Christian Schwöppe, Caroline Zerbst, et al.
Radiology|June 15, 2007
Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in miceThorsten Persigehl, Ralf Bieker, Lars Matuszewski, et al.
Pageof 7